Drip and Ship versus Mothership Model in the Middle Cerebral Artery Stroke: A Propensity-Matched Real-World Analysis Through National Inpatient Sample Data.


Journal

World neurosurgery
ISSN: 1878-8769
Titre abrégé: World Neurosurg
Pays: United States
ID NLM: 101528275

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 26 04 2022
revised: 28 08 2022
accepted: 30 08 2022
pubmed: 12 9 2022
medline: 18 2 2023
entrez: 11 9 2022
Statut: ppublish

Résumé

The superiority of mechanical thrombectomy and intravenous thrombolysis versus intravenous thrombolysis alone for acute ischemic stroke caused by large vessel occlusions has been established. This treatment can be organized into 2 models: drip and ship (DS) versus mothership (MS). We analyzed the National Inpatient Sample (NIS) data to compare the outcomes between these models in real-world settings. NIS data were queried for 2017-2018 and propensity matching was used to match the differences. Outcomes for each group (disability at discharge and procedural complications) were compared. A total of 1226 patients were included in analysis (DS, n = 540; MS, n = 686) and groups were matched with respect to age, gender, and comorbidities. A total of 930 patients were included in the final analysis after propensity matching (DS, n = 465, MS, n = 465). The mean age in the DS group was 68.9 years (standard deviation [SD], 14.7) and 69.4 years (SD, 14) in the MS group (P = 0.752). The mean National Institutes of Health Stroke Scale score was 16.75 (SD, 6.07) in the DS group and 16.54 (SD, 5.99) in the MS group (P = 0.478). At discharge, minimal disability was noted in 22.4% in the DS group versus 26.2% in the MS group (P = 0.293). In-hospital mortality was lower in the MS group (8.8% vs. 7.1%; P = 0.32). The intracerebral hemorrhage (ICH) and intraventricular hemorrhage (IVH) rates were higher in the DS group (ICH, 24.3% vs. 18.7%; IVH, 2.4% vs. 0.9%) (ICH, P = 0.038; IVH, P = 0.068). Analyzing the efficacy and safety profile of DS versus MS models with the NIS database showed a trend toward better discharge outcomes and lower mortality for the MS group, although it did not reach statistical significance.

Sections du résumé

BACKGROUND BACKGROUND
The superiority of mechanical thrombectomy and intravenous thrombolysis versus intravenous thrombolysis alone for acute ischemic stroke caused by large vessel occlusions has been established. This treatment can be organized into 2 models: drip and ship (DS) versus mothership (MS). We analyzed the National Inpatient Sample (NIS) data to compare the outcomes between these models in real-world settings.
METHODS METHODS
NIS data were queried for 2017-2018 and propensity matching was used to match the differences. Outcomes for each group (disability at discharge and procedural complications) were compared.
RESULTS RESULTS
A total of 1226 patients were included in analysis (DS, n = 540; MS, n = 686) and groups were matched with respect to age, gender, and comorbidities. A total of 930 patients were included in the final analysis after propensity matching (DS, n = 465, MS, n = 465). The mean age in the DS group was 68.9 years (standard deviation [SD], 14.7) and 69.4 years (SD, 14) in the MS group (P = 0.752). The mean National Institutes of Health Stroke Scale score was 16.75 (SD, 6.07) in the DS group and 16.54 (SD, 5.99) in the MS group (P = 0.478). At discharge, minimal disability was noted in 22.4% in the DS group versus 26.2% in the MS group (P = 0.293). In-hospital mortality was lower in the MS group (8.8% vs. 7.1%; P = 0.32). The intracerebral hemorrhage (ICH) and intraventricular hemorrhage (IVH) rates were higher in the DS group (ICH, 24.3% vs. 18.7%; IVH, 2.4% vs. 0.9%) (ICH, P = 0.038; IVH, P = 0.068).
CONCLUSIONS CONCLUSIONS
Analyzing the efficacy and safety profile of DS versus MS models with the NIS database showed a trend toward better discharge outcomes and lower mortality for the MS group, although it did not reach statistical significance.

Identifiants

pubmed: 36089277
pii: S1878-8750(22)01256-6
doi: 10.1016/j.wneu.2022.08.142
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e1103-e1114

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Sandeep Kandregula (S)

Department of Neurosurgery, Ochsner LSU Health Shreveport, Shreveport, Louisiana, USA.

Amey Savardekar (A)

Department of Neurosurgery, Ochsner LSU Health Shreveport, Shreveport, Louisiana, USA.

Pankaj Sharma (P)

Department of Neurology, Ochsner LSU Health Shreveport, Shreveport, Louisiana, USA.

Jerry Mclarty (J)

Department of Oncology, Feist Weiller Cancer Center, LSU Health Shreveport, Shreveport, Louisiana, USA.

Jennifer Kosty (J)

Department of Neurosurgery, Ochsner LSU Health Shreveport, Shreveport, Louisiana, USA.

Krystle Trosclair (K)

Department of Neurosurgery, Ochsner LSU Health Shreveport, Shreveport, Louisiana, USA.

William Christopher Newman (WC)

Department of Neurosurgery, Ochsner LSU Health Shreveport, Shreveport, Louisiana, USA.

Hugo Cuellar (H)

Department of Radiology, Ochsner LSU Health Shreveport, Shreveport, Louisiana, USA.

Bharat Guthikonda (B)

Department of Neurosurgery, Ochsner LSU Health Shreveport, Shreveport, Louisiana, USA. Electronic address: bguthi@lsuhsc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH